Check out the work from the original founder who's been researching this forever. The plant based origin of this type treatment will market extremely well. If we get to commercialisation , which I think we will, HXL is going to be worth a fortune. Especially with the very good capital management and very low dilution.
- Forums
- ASX - By Stock
- HXL
- IPO - Hexima Limited
IPO - Hexima Limited, page-30
Featured News
Add HXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $1.67M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $4K | 400K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1363156 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 322815 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1363156 | 0.010 |
4 | 533429 | 0.009 |
1 | 100000 | 0.008 |
1 | 130000 | 0.007 |
5 | 1583135 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 322815 | 2 |
0.013 | 1388199 | 3 |
0.014 | 588589 | 2 |
0.015 | 631062 | 1 |
0.018 | 350000 | 1 |
Last trade - 12.55pm 06/05/2024 (20 minute delay) ? |
Featured News
HXL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online